The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Previous

An Overview of the HCV Drug Development Process

Back to News Homepage

Next

Adding Boceprevir to HCV Combination Therapy Doubles Success Rate

Kidney Transplant Helps Natalie Cole Battle Hep C

May 22, 2009

Print this page

Putting her dialysis days in the past, R & B singer and Hepatitis C survivor Natalie Cole receives a kidney transplant.

Natalie Cole receives new kidney

Wed May 20, 2009

LOS ANGELES (Reuters) – Rhythm and blues singer Natalie Cole, who has been battling Hepatitis C, received a new kidney in Los Angeles and is resting comfortably, her spokeswoman said on Wednesday.

Cole, the 59-year-old daughter of R&B legend Nat “King” Cole, underwent surgery at Cedars-Sinai Medical Center in Los Angeles on Tuesday. The kidney came from a deceased organ donor, the spokeswoman said in a statement.

She has been receiving kidney dialysis three times a week since September, even as she toured the world to promote her new album, “Still Unforgettable.” Cole will recuperate for the next three to four months, forcing her to postpone a summer tour, the statement said.

The singer revealed her Hepatitis C diagnosis last July, saying she probably contracted the liver disease from drug use more than 30 years ago.

Hepatitis C is a blood-borne infectious disease that can cause inflammation of the liver, and in extreme cases, liver cancer. It is usually contracted through transfusions of unscreened blood, or by injecting or inhaling drugs.

Cole has won nine Grammys in a 30-year career that has included albums such as “Everlasting” and “Unforgettable … With Love,” which featured her singing a duet with her late father via electronic technology.

(Reporting by Dean Goodman; editing by Paul Simao)

© Thomson Reuters 2009 All rights reserved

URL for Article Source: http://www.reuters.com/article/entertainmentNews/idUSTRE54J70J20090520

No Comments - be the first!
Share
Share

Previous

An Overview of the HCV Drug Development Process

Back to News Homepage

Next

Adding Boceprevir to HCV Combination Therapy Doubles Success Rate

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.